Search company, investor...

Yierkang

bjyek.com

Founded Year

1997

Stage

Corporate Majority | Acquired

Valuation

$0000 

About Yierkang

On April 20th, 2022, Bloomage BioTech acquired a majority stake in Yierkang for $36.44M. Yierkang is a modern state-level high-tech enterprise integrating scientific research, production, and sales. The company provides collagen medical terminal products, including collagen sponges and artificial bone. The company was founded in 1997 and is based in Beijing, China.

Headquarters Location

No. 9, Jinyuan Road, Industrial Development Zone Daxing District

Beijing, Beijing,

China

010-60213636

Missing: Yierkang's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Yierkang's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Yierkang Frequently Asked Questions (FAQ)

  • When was Yierkang founded?

    Yierkang was founded in 1997.

  • Where is Yierkang's headquarters?

    Yierkang's headquarters is located at No. 9, Jinyuan Road, Industrial Development Zone, Beijing.

  • What is Yierkang's latest funding round?

    Yierkang's latest funding round is Corporate Majority.

  • Who are the investors of Yierkang?

    Investors of Yierkang include Bloomage BioTech.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.